Dr Anne d’Andon (MD) has worked on the development of health products, particularly in the field of rare diseases. She successively headed the research departments of two patient associations, Vaincre la mucoviscidose and the Association Française contre les Myopathies – Téléthon. Anne d’Andon was then Deputy Medical Director of the Genzyme laboratory where she participated in the development of innovative therapy drugs.
She headed the drug evaluation department of the French National Authority for Health (HAS) for more than 10 years, developing a national and international expertise in health technology assessment. She joined CEMKA in 2019 as medical director for the company’s various business units.
Since April 2021, Anne d’Andon has been running an independent consultancy business while maintaining her links with CEMKA to whom she brings her expertise and extensive knowledge of market access firstname.lastname@example.org